Connect
MJA
MJA

Misleading advertising of PI-based drug information?*

Jim R Stockigt
Med J Aust 2008; 188 (11) || doi: 10.5694/j.1326-5377.2008.tb01839.x
Published online: 2 June 2008

* It should be noted that the question mark in the title was added at the Editor's discretion.

The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.


  • 1 Epworth Hospital, Melbourne, VIC.
  • 2 Department of Endocrinology and Diabetes, The Alfred Hospital, Melbourne, VIC.
  • 3 Monash University, Melbourne, VIC.


Correspondence: jrs@netspace.net.au

  • 1. Medicines Australia code of conduct: breaches. Australian Prescriber 2007; 30: 153-155.
  • 2. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79. <MJA full text>
  • 3. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications [matters arising]. Med J Aust 2007; 186: 483-485. <MJA full text>
  • 4. Dowden JS. Product information past perfect [editorial]. Med J Aust 2007; 186: 51-52. <MJA full text>

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.